New Human Embryonic Stem Cell Study For Dry AMD And Stargardt’s Macular Dystrophy
Two patients have been treated using RPE (retinal pigment epithelial) cells derived from hESCs (human embryonic stem cells) in two Phase 1/2 clinical trials for dry age-related macular degeneration and Stargardt's macular dystrophy, Advanced Cell Technology Inc. has announced.